Internal Medicine, Medical Oncology · New Ulm, MN
NPI
1881982494
Since 2011
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1217 8th St N
New Ulm, MN, 56073
Phone (507) 217-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$203K
3,935 services
Medicare patients, 2024
421
Average age 76
Drug cost, 2024
$2.8M
1,851 prescriptions
Company payments, 2024
$26
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anas A Khanfar was code 99215 (office e&m - established), 1,195 times for 253 patients. In total Anas A Khanfar billed 3,935 services in 32 codes, and Medicare paid $203K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 1,195 | 253 | $104.41 | $125K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 1,117 | 301 | $12.46 | $14K |
| 99214 Office E&M - Established | Facility | 230 | 151 | $66.13 | $15K |
| 99215 Office E&M - Established | Office | 191 | 97 | $128.79 | $25K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 172 | 96 | $12.30 | $2,116 |
| 36415 Venipuncture Blood Collection | Office | 76 | 30 | $8.65 | $657 |
| 99214 Office E&M - Established | Office | 69 | 49 | $94.46 | $6,518 |
| 85025 Blood Count | Office | 68 | 31 | $7.61 | $517 |
| 80053 Clinical Chemistry | Office | 66 | 31 | $10.35 | $683 |
| 99205 Office E&M - New | Facility | 62 | 62 | $134.67 | $8,349 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 15 | 14 | $23.75 | $356 |
By year: 2022 $166K for 1,576 services; 2023 $189K for 3,418 services; 2024 $203K for 3,935 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 76 | 30 | $8.65 | $657 |
| 85025 Blood Count | 68 | 31 | $7.61 | $517 |
| 80053 Clinical Chemistry | 66 | 31 | $10.35 | $683 |
Medicare prescription drug claims, 2024
In 2024, the drug Anas A Khanfar prescribed most often to Medicare patients was Anastrozole, with 220 prescriptions and refills. In total Anas A Khanfar wrote 1,851 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 220 | 555 | 62 | $4,448 |
| Letrozole Generic | 131 | 294 | 30 | $3,746 |
| Potassium Chloride Generic | 108 | 157 | 36 | $1,816 |
| Hydroxyurea Generic | 77 | 164 | 17 | $2,480 |
| Dexamethasone Generic | 76 | 103 | 32 | $1,919 |
| Acyclovir Generic | 73 | 89 | 16 | $787 |
| Ondansetron Hcl Generic | 68 | 68 | 37 | $299 |
| Tamoxifen Citrate Generic | 63 | 131 | 15 | $1,806 |
| Prochlorperazine Maleate Generic | 61 | 61 | 36 | $518 |
| Eliquis Apixaban | 50 | 62 | Under 11 | $35K |
| Exemestane Generic | 50 | 88 | 14 | $6,226 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 49 | 61 | 11 | $187 |
| Furosemide Generic | 49 | 84 | 15 | $222 |
| Allopurinol Generic | 45 | 64 | Under 11 | $143 |
| Olanzapine Generic | 38 | 42 | 20 | $1,636 |
Brand drugs: 251 claims; generic drugs: 1,600 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Anas A Khanfar $26 ($26 in general payments such as food, travel and fees) from 1 company. The largest payer was Pfizer Inc. with $26.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 1 | $26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.